FDA Import Refusal AEK-2011977-1/40003/1 — Cipla Limited
The FDA refused shipment AEK-2011977-1/40003/1 from Cipla Limited (India) on Sep 9, 2026. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 9, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75